Salutissp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2008-02-22
Share capital
50,000.00 PLN
Registered address
Trześniowska 59 I, 20-227 Lublin, Poland
Website
Electronic delivery address
AE:PL-50961-44470-WAUWA-20

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 2 of 6 financial statements were filed late (the longest delay 217 days for 2021).

  • 2025not filed
  • 202413/07/2025
  • 202329/06/2024
  • 202214/07/2023
  • 202117/02/2023
  • 202001/04/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Top 34%
Division · Retail trade2,979 / 13,252
Top 22%
Voivodeship · Lubelskie1,668 / 15,986
Top 10%
Country · Poland54,564 / 495,976
Top 11%

Results vs industry

Revenue
This companyUSD 3.68mMedianUSD 1.92mAverageUSD 5.21m
Net profit
This companyUSD 112.11kMedianUSD 21.05kAverageUSD 87.01k
Operating costs
This companyUSD 3.50mMedianUSD 1.88mAverageUSD 5.05m
Assets
This companyUSD 1.14mMedianUSD 544.32kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Salutis has been an NFZ healthcare provider since 2008. In 2026 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Other services provided in pharmacieslubelskie1USD 0.00

Authorized Representatives

Andrzej Zbigniew Oleszczakage 53 – President of the Management Board
Paweł Jan Oleszczakage 59 – Vice President of the Management Board

Manner of representation

In the case of a one-person management board, the company is represented, declarations of will are made and documents are signed on behalf of the company by the President of the Management Board, acting independently. In the case of a multi-member management board, the company is represented, declarations of will are made and documents are signed on behalf of the company by the President of the Management Board acting independently, or by each Vice-President of the Management Board acting independently.

Ownership

OwnerSharesShare valueStake
50$6,753.1150%
50$6,753.1150%

Andrzej Zbigniew Oleszczak and Paweł Jan Oleszczak hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2008-03-01.

  • mBank
    04 1140 2004 0000 3102 8036 4968
  • mBank
    13 1140 2004 0000 3902 7480 6993
  • mBank
    94 1140 2004 0000 3902 7480 7281

Debt

No entries in the National Debtors Register (KRZ).

Public aid

10 public aid cases recorded, with a total value of $111,820.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$9,261
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$4,950
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$85,781

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Fragalsp. z o.o.
Modrzewscysp. j.
Ms-Pharmsp. z o.o. + limited partnership
Farmjug Agsp. z o.o.
MagmaxS.A.
Adpharmasp. z o.o.
Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j.
Novopharm - Millersp. j.
Pikadasp. z o.o.
Vitasp. z o.o.

Change history

DateEvent
2017-02-27PKD change
2016-12-20Switch to PKD 2007
2008-02-22Entered in the register

FAQ

Last updated: 2026-04-15